- Home
- PRGO vs HROW Comparison
PRGO vs HROW Comparison
Compare PRGO & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRGO
- HROW
- Stock Information
- Founded
- PRGO 1887
- HROW 1998
- Country
- PRGO Ireland
- HROW United States
- Employees
- PRGO N/A
- HROW N/A
- Industry
- PRGO Biotechnology: Pharmaceutical Preparations
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- PRGO Health Care
- HROW Health Care
- Exchange
- PRGO Nasdaq
- HROW Nasdaq
- Market Cap
- PRGO 1.7B
- HROW 1.4B
- IPO Year
- PRGO 1991
- HROW N/A
- Fundamental
- Price
- PRGO $13.41
- HROW $41.34
- Analyst Decision
- PRGO Buy
- HROW Strong Buy
- Analyst Count
- PRGO 4
- HROW 8
- Target Price
- PRGO $22.50
- HROW $68.86
- AVG Volume (30 Days)
- PRGO 4.5M
- HROW 724.7K
- Earning Date
- PRGO 11-05-2025
- HROW 11-10-2025
- Dividend Yield
- PRGO 8.64%
- HROW N/A
- EPS Growth
- PRGO N/A
- HROW N/A
- EPS
- PRGO N/A
- HROW N/A
- Revenue
- PRGO $4,281,800,000.00
- HROW $250,042,000.00
- Revenue This Year
- PRGO $2.12
- HROW $43.92
- Revenue Next Year
- PRGO $0.49
- HROW $41.22
- P/E Ratio
- PRGO N/A
- HROW N/A
- Revenue Growth
- PRGO N/A
- HROW 47.83
- 52 Week Low
- PRGO $12.17
- HROW $20.85
- 52 Week High
- PRGO $30.93
- HROW $50.72
- Technical
- Relative Strength Index (RSI)
- PRGO 26.03
- HROW 58.69
- Support Level
- PRGO $12.17
- HROW $36.95
- Resistance Level
- PRGO $14.50
- HROW $41.24
- Average True Range (ATR)
- PRGO 0.47
- HROW 2.65
- MACD
- PRGO 0.06
- HROW 0.51
- Stochastic Oscillator
- PRGO 44.55
- HROW 97.78
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.